GAUDIO, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 4.207
EU - Europa 2.135
AS - Asia 1.955
SA - Sud America 337
AF - Africa 282
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
Totale 8.927
Nazione #
US - Stati Uniti d'America 4.023
SG - Singapore 925
CN - Cina 647
IT - Italia 591
IE - Irlanda 553
UA - Ucraina 490
BR - Brasile 308
CI - Costa d'Avorio 209
IN - India 204
CA - Canada 166
RU - Federazione Russa 133
SE - Svezia 79
DE - Germania 75
FR - Francia 57
KR - Corea 50
GB - Regno Unito 40
SN - Senegal 33
VN - Vietnam 29
CH - Svizzera 20
FI - Finlandia 18
NG - Nigeria 17
BD - Bangladesh 14
NL - Olanda 14
UZ - Uzbekistan 14
HK - Hong Kong 13
GR - Grecia 12
IQ - Iraq 12
AR - Argentina 10
JP - Giappone 10
TR - Turchia 10
ZA - Sudafrica 9
AT - Austria 8
EU - Europa 8
MX - Messico 8
PL - Polonia 8
LT - Lituania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
HU - Ungheria 5
SA - Arabia Saudita 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
ES - Italia 4
KE - Kenya 4
LB - Libano 4
PY - Paraguay 4
RS - Serbia 4
CO - Colombia 3
KZ - Kazakistan 3
AL - Albania 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
PE - Perù 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
A1 - Anonimo 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MK - Macedonia 1
OM - Oman 1
PF - Polinesia Francese 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.927
Città #
Santa Clara 830
Dublin 553
Singapore 549
Chandler 512
Jacksonville 406
Boardman 245
Abidjan 209
Chicago 192
Cambridge 154
Lawrence 154
Kochi 148
Andover 147
Nanjing 144
Dallas 137
Catania 131
Toronto 111
Hefei 108
Ashburn 101
Des Moines 74
Wilmington 74
Beijing 66
San Mateo 63
Seoul 50
Ottawa 46
Saint Petersburg 40
Civitanova Marche 36
Nanchang 36
Shenyang 36
Hebei 35
Dakar 33
Jiaxing 31
Palermo 29
Bremen 27
Milan 22
Changsha 21
Modica 21
Los Angeles 20
Tianjin 19
Munich 18
Seattle 17
Abuja 16
New York 16
Padova 16
São Paulo 16
Pune 15
Rome 15
Columbus 13
Hangzhou 13
Houston 13
Rio de Janeiro 12
The Dalles 12
Washington 12
Civitavecchia 11
Lappeenranta 11
Nocera Inferiore 11
Norwalk 11
Brasília 10
Falls Church 10
Moscow 10
Tokyo 10
Hong Kong 9
Mascalucia 9
Messina 9
Ann Arbor 8
Council Bluffs 8
Dong Ket 8
Phoenix 8
Redwood City 8
Belo Horizonte 7
Boston 7
Frankfurt am Main 7
Mumbai 7
Caltanissetta 6
Campinas 6
Chennai 6
Hanoi 6
Ningbo 6
Salvador 6
Baghdad 5
Budapest 5
Casalecchio di Reno 5
Frankfurt Am Main 5
Giarre 5
Ho Chi Minh City 5
Jinan 5
Lausanne 5
London 5
Redmond 5
Taizhou 5
Uberlândia 5
Zhengzhou 5
Ankara 4
Atlanta 4
Cesa 4
Changchun 4
Cologne 4
Den Haag 4
Fairfield 4
Guangzhou 4
Mexico City 4
Totale 6.130
Nome #
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 124
A rare cause of leg pain 113
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 107
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 98
A systematic review of arterial stiffness, wave reflection and air pollution 95
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 92
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 90
Augmentation index is increased in patients with inflammatory bowel disease, a meta-analysis 88
Venous thromboembolism in hospital emergency room. A retrospective study on climatic effect 88
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 82
Dehydroepiandrosterone (DHEA) replacement therapy in elderly men with osteoporosis 82
Deep vein thrombosis related to environment (Review) 82
Anticoagulants and osteoporosis 82
Correlation between family history of hypertension and haemostatic disorders 81
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 80
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 78
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 77
Alterazioni emostatiche in pazienti con arteriopatia obliterante periferica con e senza diabete 76
Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study 76
Oxidative stress in peripheral arterial disease (PAD) mechanism and biomarkers 75
A suspicious fracture 75
Donne in post-menopausa in trattamento farmacologico per la prevenzione primaria delle fratture osteoporotiche: primi dati di uno studio pilota su aderenza e persistenza alla terapia 74
Bisphosphonates in the treatment of thalassemia-associated osteoporosis 73
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a 2-years randomized, double-blind, placebo-controlled study 73
Vascular dysfunction in Cardiorenal Syndrome type 4 73
A strange case of dyspnoea 73
Apparato locomotore 72
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 72
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 72
Melorheostosis and Osteopoikilosis Clinical and Molecular Description of an Italian Case Series 72
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? 71
Paget's Disease of Bone and Cardiovascular Risk: a Pilot Study 71
Paget's bone disease is not always the culprit 70
Review: UPDATE sul metabolismo del magnesio 70
Biphosphonates prevent bone loss in thalassemia major patients 70
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 70
Effetti del raloxifene sulla densità del parenchima mammario 69
Vitamin D levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients 69
Bone islands. 68
It Is Time for a Routine Measurement of Aortic Stiffness in Inflammatory Bowel Disease 66
Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease 66
Raloxifene e rischio cardiovascolare 66
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 66
Peripheral artery disease and osteoporosis: Not only age-related (Review) 66
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 65
When the FRAX® test is applied to controlled clinical trials 64
Osteoporosis and beta-thalassemia major: Role of the IGF-I/IGFBP-III axis 64
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 64
Vascular dysfunction of COVID-19 is partially reverted in the long-term 64
Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience 63
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis 62
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate 61
Heredity of the haemostatic disorders in non insulin dependent diabetes (NIDDM) 61
The relationship between inhibitors of the Wnt signaling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus 61
More is not better 61
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 60
Il neridronato previene il bone loss durante la terapia antiandrogena per il cancro prostatico 60
Effetti del raloxifene sulla secrezione ipofisaria 60
I bifosfonati prevengono la perdita d'osso nei pazienti thalassemici 60
Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism 60
Reply to Ialongo et al. Vitamin D, SARS-CoV-2 and causal associations in transversal studies: The time-series analysis to reveal potential confounders. comment on “gaudio et al. vitamin d levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients. Int. j. environ. res. public health 2021, 18, 3491” 60
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 59
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 59
Osteoprotegerina ed osteoporosi nei thalassemici 59
Insights from experiences on antiplatelet drugs in stroke prevention: A review 59
Effetti della somministrazione di EPO sul metabolismo osseo nel ratto 58
Raloxifene and pituitary secretion in post-menopausal women 58
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 58
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 57
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 57
Successful neridronate therapy in pregnancy-associated osteoporosis 57
Hemostatic changes in vasculitides 57
Ridotta risposta terapeutica all' alendronato in pazienti depresse affette da osteoporosi 57
Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women 57
Hemostatic effects of diets containing olive or soy oil in hypertensive patients 56
Livelli circolanti di citochine osteotrope e rimodellamento osseo nei pazienti thalassemici 56
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 56
Livelli sierici di osteoprotegerina e markers del turnover osseo durante il trattamento con raloxifene: dati preliminari 55
What changed in the Italian internal medicine and geriatric wards during the lockdown 55
Riduzione della densità minerale volumetrica in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 54
Effects of agonistic physical activity on the activation of WNT/beta-catenin signaling 54
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 54
Response to Letter to the Editor: "Methodological Issues Regarding Cortisol Secretion, Sensitivity, and Activity are Associated With Hypertension in Postmenopausal Eucortisolemic Women" 54
Hematological Diseases and Osteoporosis 54
Relationships between osteoprotegerin, receptor activator of the nuclear factor kB ligand and serum levels and carotid intima-media thickness in patients with type 2 diabetes mellitus. 53
Effects of administration of Dehydroepiandrosterone (DHEA) on male senile osteoporosis 53
Rete Osteoporosi Sicilia (Sicilian Osteoporosis Network): an IT platform for the improvement of diagnosis and treatment of osteoporosis in Sicily. 53
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 52
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus 51
Ultrasonografia ossea e DEXA nella valutazione dell' osteoporosi secondaria ad insufficienza renale cronica in trattamento sostitutivo emodialitico 51
Neridronate in the treatment of thalassemia-induced osteoporosis 51
Effetti del fitoestrogeno genisteina sul metabolismo osseo in donne in postmenopausa:COFIN 2002 dati a 12 mesi 51
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 50
Erythropoietin: A novel DABA? 50
Effetti del Raloxifene sulla secrezione ipofisaria in post-menopausa 50
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 50
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle 50
Role of genetic pattern on bone mineral density in thalassemic patients 50
Handgrip strength to discriminate high fracture risk in type 2 diabetes mellitus patients. 50
Eritropoietina: un nuovo D.A.B.A.? 49
Totale 6.617
Categoria #
all - tutte 37.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021777 0 0 90 22 245 38 100 8 74 49 104 47
2021/20221.117 112 156 14 20 184 15 162 43 102 2 59 248
2022/20231.705 164 66 22 143 189 308 7 261 418 27 46 54
2023/2024802 38 141 49 38 38 177 6 55 2 30 130 98
2024/20253.002 18 428 151 96 673 380 55 124 156 346 341 234
2025/2026681 332 253 96 0 0 0 0 0 0 0 0 0
Totale 9.267